← All companies

ZLAB

Zai Lab Limited

ZLAB Nasdaq Pharmaceutical Preparations EDGAR ↗

$18.18

-0.03 -0.16%

Key statistics

from XBRL data in SEC filings

Market cap

$20.1B

Revenue (TTM)

$447M

Net income (TTM)

-$178M

EPS (TTM)

$-0.17

P/E ratio

—

Dividend yield

—

Free cash flow

-$159M

Cash

$651M

Total assets

$1.10B

Gross margin

0.0%

52-week range

$15.96 – $39.64

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 17, 2026 8-K Director or officer change May 21, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Entered a material agreement; Took on a direct financial obligation Oct 16, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jan 3, 2025 8-K Entered a material agreement; Other events Nov 15, 2024 8-K Other events Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Entered a material agreement; Took on a direct financial obligation Jul 9, 2024 8-K Director or officer change; Shareholder vote results Jun 18, 2024 8-K Director or officer change; Regulation FD disclosure Jun 11, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Entered a material agreement; Took on a direct financial obligation Feb 8, 2024 10-K/A Fiscal year ended 2022-12-31 Dec 22, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 10-Q Quarter ended 2023-06-30 Aug 7, 2023 8-K Results of operations (earnings release) Aug 7, 2023 8-K Director or officer change; Regulation FD disclosure Jul 6, 2023 8-K Regulation FD disclosure Jun 30, 2023 8-K Shareholder vote results; Regulation FD disclosure Jun 20, 2023 8-K Other events Jun 6, 2023